Cameco (CCJ) to Release Earnings on Tuesday

Cameco (NYSE:CCJ) (TSE:CCO) is anticipated to release its Q1 2026 results before the market opens on Tuesday, May 5th. Analysts expect Cameco to post earnings of $0.2579 per share and revenue of $602.76 million for the quarter. Parties can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Tuesday, May 5, 2026 at 8:00 AM ET.

Cameco (NYSE:CCJ) (TSE:CCO) last announced its quarterly earnings data on Friday, February 13th. The basic materials company reported $0.36 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.07. The firm had revenue of $874.57 million for the quarter, compared to analyst estimates of $782.13 million. Cameco had a return on equity of 9.35% and a net margin of 17.00%.The business’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same period last year, the company earned $0.36 EPS. On average, analysts expect Cameco to post $1 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Cameco Trading Down 6.0%

CCJ traded down $7.33 during mid-day trading on Tuesday, reaching $115.78. The stock had a trading volume of 1,652,062 shares, compared to its average volume of 3,932,950. The stock has a market capitalization of $50.43 billion, a P/E ratio of 119.39, a P/E/G ratio of 2.26 and a beta of 1.02. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.68 and a current ratio of 2.47. The firm’s fifty day simple moving average is $114.85 and its two-hundred day simple moving average is $104.80. Cameco has a 52 week low of $43.83 and a 52 week high of $135.24.

Institutional Trading of Cameco

Several hedge funds and other institutional investors have recently modified their holdings of the company. Morgan Stanley raised its stake in shares of Cameco by 7.0% in the 4th quarter. Morgan Stanley now owns 4,978,333 shares of the basic materials company’s stock valued at $455,468,000 after purchasing an additional 323,693 shares during the period. The Manufacturers Life Insurance Company raised its stake in shares of Cameco by 7.4% in the 4th quarter. The Manufacturers Life Insurance Company now owns 2,911,918 shares of the basic materials company’s stock valued at $267,181,000 after purchasing an additional 200,561 shares during the period. Progeny 3 Inc. raised its stake in shares of Cameco by 5.4% in the 2nd quarter. Progeny 3 Inc. now owns 2,442,732 shares of the basic materials company’s stock valued at $181,324,000 after purchasing an additional 124,600 shares during the period. Amundi raised its stake in shares of Cameco by 5.9% in the 4th quarter. Amundi now owns 2,349,070 shares of the basic materials company’s stock valued at $214,916,000 after purchasing an additional 130,436 shares during the period. Finally, Marshall Wace LLP raised its stake in shares of Cameco by 7,481.3% in the 4th quarter. Marshall Wace LLP now owns 1,752,571 shares of the basic materials company’s stock valued at $160,343,000 after purchasing an additional 1,729,454 shares during the period. Institutional investors and hedge funds own 70.21% of the company’s stock.

Analyst Upgrades and Downgrades

CCJ has been the topic of a number of recent research reports. The Goldman Sachs Group reiterated a “buy” rating and issued a $131.00 price objective on shares of Cameco in a research report on Wednesday, February 4th. William Blair started coverage on Cameco in a research note on Monday, April 20th. They set an “outperform” rating on the stock. TD Securities downgraded Cameco from a “strong-buy” rating to a “hold” rating in a research note on Thursday, March 26th. Sanford C. Bernstein reaffirmed an “outperform” rating and set a $147.00 price objective on shares of Cameco in a research note on Thursday, February 5th. Finally, Zacks Research downgraded Cameco from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 18th. Twelve research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $150.40.

Cameco Company Profile

Cameco Corporation (NYSE: CCJ) is a leading producer of uranium and a supplier to the global nuclear power industry. Headquartered in Saskatoon, Saskatchewan, Canada, the company is engaged in the exploration, mining, milling and sale of uranium concentrate, commonly known as yellowcake, which is used as fuel for nuclear reactors. Cameco also participates in services and activities that support the front end of the nuclear fuel cycle, including processing and marketing of uranium to utilities under long‑term and spot contracts.

The company’s operations have historically centered in Canada and the United States, where it operates and develops uranium mining and processing properties.